ctrl K

AI Score

Unlock

Prelude Therapeutics (PRLD)

AI Score

Unlock

0.74

-0.02 (-2.50%)

At close: Mar 03, 2025, 12:26 PM

Prelude Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.17M	3.04M	2.24M	542K	382K	149K
Gross Profit	-1.17M	-3.04M	-2.24M	-542K	-382K	-149K
Operating Income	-132.28M	-123.54M	-113.73M	-58.76M	-28.11M	-14.97M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-121.83M	-115.44M	-111.69M	-56.93M	-27.57M	-14.68M
Net Income	-121.83M	-107.34M	-110.78M	-56.93M	-27.57M	-14.68M
Selling & General & Admin	28.88M	30.65M	26.96M	10.59M	3.83M	2.35M
Research & Development	103.39M	92.89M	86.78M	48.18M	24.28M	12.62M
Other Expenses	-1	8.1M	2.04M	1.83M	539K	295K
Operating Expenses	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Income Tax	n/a	-8.1M	-915K	335.7K	210.14K	295K
Shares Outstanding (Basic)	60.36M	47.37M	47.6M	43.71M	32.4M	32.11M
Shares Outstanding (Diluted)	60.36M	47.37M	47.6M	43.71M	32.4M	32.11M
EPS (Basic)	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EPS (Diluted)	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EBITDA	-131.11M	-122.22M	-112.82M	-58.22M	-27.73M	-14.83M
Depreciation & Amortization	1.17M	3.04M	2.24M	542K	382K	149K